Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

1.

Further Characterization of the Bifunctional HIV Entry Inhibitor sCD4-FIT45.

Falkenhagen A, Joshi S.

Mol Ther Nucleic Acids. 2017 Jun 16;7:387-395. doi: 10.1016/j.omtn.2017.04.017. Epub 2017 Apr 22.

2.

Comprehensive Mapping of HIV-1 Escape from a Broadly Neutralizing Antibody.

Dingens AS, Haddox HK, Overbaugh J, Bloom JD.

Cell Host Microbe. 2017 Jun 14;21(6):777-787.e4. doi: 10.1016/j.chom.2017.05.003. Epub 2017 Jun 1.

PMID:
28579254
3.

Tryptophan 375 stabilizes the outer-domain core of gp120 for HIV vaccine immunogen design.

Hu D, Bowder D, Wei W, Thompson J, Wilson MA, Xiang SH.

Vaccine. 2017 May 25;35(23):3067-3075. doi: 10.1016/j.vaccine.2017.04.054. Epub 2017 Apr 29.

4.

Dense Array of Spikes on HIV-1 Virion Particles.

Stano A, Leaman DP, Kim AS, Zhang L, Autin L, Ingale J, Gift SK, Truong J, Wyatt RT, Olson AJ, Zwick MB.

J Virol. 2017 Jun 26;91(14). pii: e00415-17. doi: 10.1128/JVI.00415-17. Print 2017 Jul 15.

PMID:
28446665
5.

Identification and specificity of broadly neutralizing antibodies against HIV.

McCoy LE, Burton DR.

Immunol Rev. 2017 Jan;275(1):11-20. doi: 10.1111/imr.12484. Review.

6.

Neutralizing Monoclonal Antibodies to Fight HIV-1: On the Threshold of Success.

Jaworski JP, Vendrell A, Chiavenna SM.

Front Immunol. 2017 Jan 11;7:661. doi: 10.3389/fimmu.2016.00661. eCollection 2016. Review.

7.

Neutralization Takes Precedence Over IgG or IgA Isotype-related Functions in Mucosal HIV-1 Antibody-mediated Protection.

Astronomo RD, Santra S, Ballweber-Fleming L, Westerberg KG, Mach L, Hensley-McBain T, Sutherland L, Mildenberg B, Morton G, Yates NL, Mize GJ, Pollara J, Hladik F, Ochsenbauer C, Denny TN, Warrier R, Rerks-Ngarm S, Pitisuttithum P, Nitayapan S, Kaewkungwal J, Ferrari G, Shaw GM, Xia SM, Liao HX, Montefiori DC, Tomaras GD, Haynes BF, McElrath JM.

EBioMedicine. 2016 Dec;14:97-111. doi: 10.1016/j.ebiom.2016.11.024. Epub 2016 Nov 21.

8.

Structure-based Design of Cyclically Permuted HIV-1 gp120 Trimers That Elicit Neutralizing Antibodies.

Kesavardhana S, Das R, Citron M, Datta R, Ecto L, Srilatha NS, DiStefano D, Swoyer R, Joyce JG, Dutta S, LaBranche CC, Montefiori DC, Flynn JA, Varadarajan R.

J Biol Chem. 2017 Jan 6;292(1):278-291. doi: 10.1074/jbc.M116.725614. Epub 2016 Nov 22.

PMID:
27879316
9.

Presenting native-like trimeric HIV-1 antigens with self-assembling nanoparticles.

He L, de Val N, Morris CD, Vora N, Thinnes TC, Kong L, Azadnia P, Sok D, Zhou B, Burton DR, Wilson IA, Nemazee D, Ward AB, Zhu J.

Nat Commun. 2016 Jun 28;7:12041. doi: 10.1038/ncomms12041.

10.

Clonify: unseeded antibody lineage assignment from next-generation sequencing data.

Briney B, Le K, Zhu J, Burton DR.

Sci Rep. 2016 Apr 22;6:23901. doi: 10.1038/srep23901.

11.

Probing the Impact of Local Structural Dynamics of Conformational Epitopes on Antibody Recognition.

Liang Y, Guttman M, Davenport TM, Hu SL, Lee KK.

Biochemistry. 2016 Apr 19;55(15):2197-213. doi: 10.1021/acs.biochem.5b01354. Epub 2016 Apr 4.

12.

HIV-1 Vaccine-elicited Antibodies Reverted to Their Inferred Naive Germline Reveal Associations between Binding Affinity and in vivo Activation.

Dai K, Khan SN, Wang Y, He L, Guenaga J, Ingale J, Sundling C, O'Dell S, McKee K, Phad G, Corcoran M, Wilson R, Mascola JR, Zhu J, Li Y, Karlsson Hedestam GB, Wyatt RT.

Sci Rep. 2016 Feb 16;6:20987. doi: 10.1038/srep20987.

13.

Mechanisms of escape from the PGT128 family of anti-HIV broadly neutralizing antibodies.

Krumm SA, Mohammed H, Le KM, Crispin M, Wrin T, Poignard P, Burton DR, Doores KJ.

Retrovirology. 2016 Feb 2;13:8. doi: 10.1186/s12977-016-0241-5.

14.

Broadly Neutralizing Antibodies against HIV-1 As a Novel Aspect of the Immune Response.

Shcherbakov DN, Bakulina AY, Karpenko LI, Ilyichev AA.

Acta Naturae. 2015 Oct-Dec;7(4):11-21.

15.

The HIV glycan shield as a target for broadly neutralizing antibodies.

Doores KJ.

FEBS J. 2015 Dec;282(24):4679-91. doi: 10.1111/febs.13530. Epub 2015 Oct 23. Review.

16.

Structure-Based Design of a Small Molecule CD4-Antagonist with Broad Spectrum Anti-HIV-1 Activity.

Curreli F, Kwon YD, Zhang H, Scacalossi D, Belov DS, Tikhonov AA, Andreev IA, Altieri A, Kurkin AV, Kwong PD, Debnath AK.

J Med Chem. 2015 Sep 10;58(17):6909-6927. doi: 10.1021/acs.jmedchem.5b00709. Epub 2015 Aug 28.

17.

Incomplete Neutralization and Deviation from Sigmoidal Neutralization Curves for HIV Broadly Neutralizing Monoclonal Antibodies.

McCoy LE, Falkowska E, Doores KJ, Le K, Sok D, van Gils MJ, Euler Z, Burger JA, Seaman MS, Sanders RW, Schuitemaker H, Poignard P, Wrin T, Burton DR.

PLoS Pathog. 2015 Aug 12;11(8):e1005110. doi: 10.1371/journal.ppat.1005110. eCollection 2015 Aug.

18.

Murine Antibody Responses to Cleaved Soluble HIV-1 Envelope Trimers Are Highly Restricted in Specificity.

Hu JK, Crampton JC, Cupo A, Ketas T, van Gils MJ, Sliepen K, de Taeye SW, Sok D, Ozorowski G, Deresa I, Stanfield R, Ward AB, Burton DR, Klasse PJ, Sanders RW, Moore JP, Crotty S.

J Virol. 2015 Oct;89(20):10383-98. doi: 10.1128/JVI.01653-15. Epub 2015 Aug 5.

19.

CATNAP: a tool to compile, analyze and tally neutralizing antibody panels.

Yoon H, Macke J, West AP Jr, Foley B, Bjorkman PJ, Korber B, Yusim K.

Nucleic Acids Res. 2015 Jul 1;43(W1):W213-9. doi: 10.1093/nar/gkv404. Epub 2015 Jun 4.

20.

Immunogenic Display of Purified Chemically Cross-Linked HIV-1 Spikes.

Leaman DP, Lee JH, Ward AB, Zwick MB.

J Virol. 2015 Jul;89(13):6725-45. doi: 10.1128/JVI.03738-14. Epub 2015 Apr 15.

Supplemental Content

Support Center